Impact of Transcranial Doppler Ultrasound on Logistics and Outcomes in Stroke Thrombolysis: Results From the SITS-ISTR
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
29844031
DOI
10.1161/strokeaha.118.021485
PII: STROKEAHA.118.021485
Knihovny.cz E-zdroje
- Klíčová slova
- infarction, cerebral, reperfusion, stroke, thrombolysis, therapeutic, tissue-type plasminogen activator, ultrasonography, Doppler, transcranial,
- MeSH
- čas zasáhnout při rozvinutí nemoci MeSH
- časové faktory MeSH
- cévní mozková příhoda diagnostické zobrazování farmakoterapie MeSH
- fibrinolytika terapeutické užití MeSH
- ischemie mozku diagnostické zobrazování farmakoterapie MeSH
- lidé středního věku MeSH
- lidé MeSH
- senioři MeSH
- tkáňový aktivátor plazminogenu terapeutické užití MeSH
- trombolytická terapie metody MeSH
- ultrasonografie dopplerovská transkraniální MeSH
- výsledek terapie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- fibrinolytika MeSH
- tkáňový aktivátor plazminogenu MeSH
BACKGROUND AND PURPOSE: Diagnostic transcranial Doppler ultrasound (TCD) is commonly used in patients with acute stroke before or during treatment with intravenous thrombolysis (IVT). We aimed to assess how much TCD delays IVT initiation and whether TCD influences outcomes. METHODS: We analyzed data from the SITS-ISTR (Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register) collected from December 2002 to December 2011. Outcomes were door-to-needle time, symptomatic intracerebral hemorrhage, functional outcome per the modified Rankin Scale, and mortality at 3 months. RESULTS: In hospitals performing any TCD pre-IVT, 1701 of 11 265 patients (15%) had TCD before IVT initiation. Door-to-needle time was higher in patients with pre-IVT TCD (74 versus 60 minutes; P<0.001). At hospitals performing any TCD during IVT infusion, of 9044 patients with IVT, 747 were examined with TCD during IVT. No treatment delay was seen with TCD during IVT. After multivariate adjustment, TCD during IVT was independently associated with modestly increased excellent functional outcome (modified Rankin Scale, 0-1; adjusted odds ratio, 1.28; 95% confidence interval, 1.06-1.55; P=0.012) and lower mortality (adjusted odds ratio, 0.73; 95% confidence interval, 0.55-0.95; P=0.022). CONCLUSIONS: We recommend that TCD, if performed, should be done during IVT infusion, to avoid treatment delay. The association of hyperacute TCD with beneficial outcomes suggests potential impact on patient management, which warrants further study.
2nd Department of Neurology Institute of Psychiatry and Neurology Warsaw Poland
Department of Clinical Neuroscience Karolinska Institutet Stockholm Sweden
Department of Neurology and Psychiatry University of Rome La Sapienza Italy
Department of Neurology and Stroke Center County Hospital Chomutov Czech Republic
Department of Neurology Hospital São João University of Porto Portugal
From the Department of Neurology Karolinska University Hospital Stockholm Sweden
Citace poskytuje Crossref.org
